Defining the role of germline genetic variants in gastric cancer tumorigenesis

Defining the role of germline genetic variants in gastric cancer tumorigenesis

Brief description of study

The research study is being conducted to better understand factors that lead to gastric (stomach) cancer, including differences in our genes that may put some people at increased risk of developing gastric cancer compared to other people. Both people with increased risk as well as people with average risk of gastric cancer will be asked to participate in this study. If you agree to join the study, at the time of an upper endoscopy that is being performed as part of your routine care, you will have a blood sample collected and extra biopsies of your stomach will be obtained during your procedure.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    stomach cancer
  • Age: - 99 Years
  • Gender: All


Updated on 09 Mar 2024. Study ID: 842961
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center